Capstan Therapeutics logo

Capstan Therapeutics, Inc.

Biotechnology

Capstan Therapeutics Stock

Capstan Therapeutics is developing in vivo RNA-based therapies for oncology, fibrosis, and inflammation-related diseases. Its platform utilizes targeted lipid nanoparticles for precise delivery and control of engineered cells, aiming to advance innovative treatments in these fields.

For more Capstan Therapeutics stock information, or to buy or sell private shares, sign up for a MicroVentures account.

Management Team

Laura Shawver Ph.D. President & Chief Executive Officer
Justin Thacker Chief Financial Officer
Priya Karmali Ph.D. Chief Technology Officer
Adrian Bot Ph.D. Founding Chief Scientific Officer, Executive Vice President of Research & Development
Haig Aghajanian Ph.D. Co-Founder & Vice President of Research
Ramin Farzaneh-Far MD Chief Medical Officer

Funding Information